Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blann

Showing results (241-250 of 420) with videos related to

Pageof 42
Sort By:
Investigative Ophthalmology & Visual Science|May 4, 2010
Continuous retinal vessel diameter measurements: the future in retinal vessel assessment?Rebekka Heitmar, Andrew D Blann, Robert P Cubbidge, et al.
The British Journal of Radiology|September 19, 2001
Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery diseaseA D Blann, R Adams, R Ashleigh, et al.
British Journal of Haematology|February 13, 2001
Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100M Homoncik, A D Blann, U Hollenstein, et al.
Journal of Thrombosis and Thrombolysis|March 5, 2016
Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysisY C Lau, Q Xiong, P Ranjit, et al.
Clinical Science (London, England : 1979)|July 5, 2003
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selectionBernard S P Chin, Christopher R Gibbs, Andrew D Blann, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factorA D Blann, D Gurney, M Wadley, et al.
Blood|September 18, 2004
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromesKaeng W Lee, Gregory Y H Lip, Muzahir Tayebjee, et al.
Thrombosis and Haemostasis|November 8, 2005
High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy menBernd Jilma, Tuende Cvitko, Astrid Winter-Fabry, et al.
Annals of Medicine|September 24, 2005
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?Bethan Freestone, Aun Yeong Chong, Hoong Sern Lim, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 1, 1996
Soluble P selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factorsA D Blann, M Seigneur, M R Boisseau, et al.
Pageof 42

Showing results (241-250 of 420) with videos related to

Sort By:
Pageof 42
Investigative Ophthalmology & Visual Science|May 4, 2010
Continuous retinal vessel diameter measurements: the future in retinal vessel assessment?Rebekka Heitmar, Andrew D Blann, Robert P Cubbidge, et al.
The British Journal of Radiology|September 19, 2001
Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery diseaseA D Blann, R Adams, R Ashleigh, et al.
British Journal of Haematology|February 13, 2001
Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100M Homoncik, A D Blann, U Hollenstein, et al.
Journal of Thrombosis and Thrombolysis|March 5, 2016
Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysisY C Lau, Q Xiong, P Ranjit, et al.
Clinical Science (London, England : 1979)|July 5, 2003
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selectionBernard S P Chin, Christopher R Gibbs, Andrew D Blann, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factorA D Blann, D Gurney, M Wadley, et al.
Blood|September 18, 2004
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromesKaeng W Lee, Gregory Y H Lip, Muzahir Tayebjee, et al.
Thrombosis and Haemostasis|November 8, 2005
High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy menBernd Jilma, Tuende Cvitko, Astrid Winter-Fabry, et al.
Annals of Medicine|September 24, 2005
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?Bethan Freestone, Aun Yeong Chong, Hoong Sern Lim, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 1, 1996
Soluble P selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factorsA D Blann, M Seigneur, M R Boisseau, et al.
Pageof 42